PDCD1 and non-small cell lung carcinoma: Jin et al. reported a greater frequency of unique memory CD8+ T cell and natural killer cell subsets in the periphery in response to anti-PD-1 therapy, further documenting the importance of high diversity of microbiota in prolonging the PFS in patient with NSCLC on anti-PD1 immunotherapy [22,23].